Allied Biotech Corporation (TPEX: 1780)
Health Care · Biotechnology · TW
NT$25.10
+5.68% today · +44.3% 1Y
Allied Biotech Corporation (TPEX: 1780) operates in the Biotechnology industry within the Health Care sector. The company is valued at $75.86M and employs 40 people.
Over the last twelve months the share price has gained 44.3%, trading between 16.80 and 36.85.
Tweenvest scores Allied Biotech Corporation across four factors: quality 81/100, value 66/100, growth 41/100, dividend 90/100. Its strongest factor is dividend.
1780 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $75.86M
- Revenue (TTM)
- $29.00M
- P/E
- 13.54
- EPS
- 1.85
- Dividend yield
- 4.98%
- Beta (5Y)
- 0.20
- 52-week high
- NT$36.85
- 52-week low
- NT$16.80
- Avg volume (3M)
- —
- Shares outstanding
- 96.24M
- Employees
- 40
- Next earnings
- —
About Allied Biotech Corporation
Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-orange hues across numerous applications. Beta-Apo-8'-Carotenal, a versatile food colorant delivering shades from rich orange to deep red. Lycopene, a valuable nutrient that provides striking red tones for incorporation into food, dietary supplements, and pharmaceutical formulations. Canthaxanthin, which contributes reddish-orange colors specifically to food and beverage products. Lutein, another carotenoid frequently derived from or associated with green leafy vegetables (like spinach, kale, and broccoli) and egg yolks. Additionally, Allied Biotech offers Nano Coenzyme Q10, an antioxidant crucial for cellular energy production. The corporation caters to a diverse clientele across the food, beverage, dietary supplement, and animal feed sectors. Established in 2001, Allied Biotech Corporation maintains its headquarters in Taipei, Taiwan.
- ISIN
- TW0001780005
- Founded
- 2001
- Listed since
- Jun 20, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.